Steven Cohen’s Amicus Therapeutics FOLD Stock Holding History

Steven Cohen’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300,000	Closed	-$4.32M	–	997
2017 Q4	$4.32M	Buy	+300,000	New	+$4.12M	0.02%	625
2017 Q3	–	Sell	-1,050,000	Closed	-$10.6M	–	932
2017 Q2	$10.6M	Buy	+1,050,000	New	+$8.45M	0.06%	375

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Steven Cohen's FOLD Position: Q2 2026 in Review

Steven Cohen sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 54,677 shares — an estimated $791K sold.

Steven Cohen first reported a position in FOLD in Q3 2014 and held it in 29 quarters. The position peaked at $87.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Steven Cohen reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 54,677 Amicus Therapeutics shares in Q2 2026, an estimated $791K.
Steven Cohen first reported a position in Amicus Therapeutics in Q3 2014 and held it in 29 quarters.
Steven Cohen's Amicus Therapeutics position peaked at $87.9M in Q2 2023.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.